Skip to content
10-Q

Quarterly Report

TENAX THERAPEUTICS, INC. TENX

0001193125-25-277793

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 11, 2025 6.24M sh
Shares Diluted Q3 2025 · Sep 30, 2025 39.74M sh
Shares Diluted Q3 2025 · Sep 30, 2025 38.64M sh
Shares Diluted Q3 2025 · Sep 30, 2024 21.16M sh
Shares Diluted Q3 2025 · Sep 30, 2024 8.28M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$22.39M
Operating Cash Flow restated Q3 2025 · Sep 30, 2024 −$11.28M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $99.4M
Stockholders Equity Q3 2025 · Sep 30, 2025 $96.21M
Stockholders Equity Q3 2025 · Jun 30, 2025 $103.33M
Stockholders Equity Q3 2025 · Mar 31, 2025 $109.29M
Stockholders Equity Q3 2025 · Dec 31, 2024 $91.99M
Stockholders Equity restated Q3 2025 · Sep 30, 2024 $97.22M
Stockholders Equity restated Q3 2025 · Jun 30, 2024 $8.88M
Stockholders Equity restated Q3 2025 · Mar 31, 2024 $12.43M
Stockholders Equity restated Q3 2025 · Dec 31, 2023 $8.1M
Current Liabilities Q3 2025 · Sep 30, 2025 $6.6M
Current Liabilities Q3 2025 · Dec 31, 2024 $4.69M
Total Liabilities Q3 2025 · Sep 30, 2025 $6.6M
Total Liabilities Q3 2025 · Dec 31, 2024 $4.69M
Current Assets Q3 2025 · Sep 30, 2025 $102.81M
Current Assets Q3 2025 · Dec 31, 2024 $96.69M
Total Assets Q3 2025 · Sep 30, 2025 $102.81M
Total Assets Q3 2025 · Dec 31, 2024 $96.69M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.40
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.96
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.19
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.37
Eps Basic Q3 2025 · Sep 30, 2025 −$0.40
Eps Basic Q3 2025 · Sep 30, 2025 −$0.96
Eps Basic Q3 2025 · Sep 30, 2024 −$0.19
Eps Basic Q3 2025 · Sep 30, 2024 −$1.37
Rd Expense Q3 2025 · Sep 30, 2025 $10.33M
Rd Expense Q3 2025 · Sep 30, 2025 $22.13M
Rd Expense restated Q3 2025 · Sep 30, 2024 $3.11M
Rd Expense restated Q3 2025 · Sep 30, 2024 $8.12M
Net Income Q3 2025 · Sep 30, 2025 −$15.8M
Net Income Q3 2025 · Sep 30, 2025 −$37.06M
Net Income Q3 2025 · Jun 30, 2025 −$10.85M
Net Income Q3 2025 · Mar 31, 2025 −$10.41M
Net Income restated Q3 2025 · Sep 30, 2024 −$3.96M
Net Income restated Q3 2025 · Sep 30, 2024 −$11.34M
Net Income restated Q3 2025 · Jun 30, 2024 −$3.58M
Net Income restated Q3 2025 · Mar 31, 2024 −$3.8M
Operating Income Q3 2025 · Sep 30, 2025 −$16.81M
Operating Income Q3 2025 · Sep 30, 2025 −$39.94M
Operating Income restated Q3 2025 · Sep 30, 2024 −$4.62M
Operating Income restated Q3 2025 · Sep 30, 2024 −$12.2M
Revenue Q3 2025 · Sep 30, 2025 $0